Hyaluronan-a high-molar-mass messenger reporting on the status of synovial joints: Part II. pathophysiological status

New Steps in Chemical and Biochemical Physics: Pure and Applied Science

Volumn , Issue , 2010, Pages 137-152

  Šoltés, Ladislav ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Glycosaminoglycans; Hyaluronan catabolism; Reactive oxygen species; Synovial fluid; Transition metals

Indexed keywords

EID: 84895283573     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (25)

1. C.A. Hitchon, H.S. El-Gabalawy, Arthritis Res. Ther., 6 (2004) 265-278.
2. M. Valko, D. Leibfritz, J. Moncol, M.T.D. Cronin, M. Mazur, J. Telser, Int. J. Biochem. Cell Biol., 39 (2007) 44-84.
3. http://www.oxisresearch.com/library/oxidative_stress.shtml (valid: December 5, 2009).
4. http://books.google.sk/books?id=a52CE0vWRXQC&pg=PA321&lpg=PA321&dq=stan dard+reduction+potential+H2O2/%E2%80%A2OH&source=bl&ots=YJL8hdl4Wh&sig =ChpmRnhvt--GEuyfkbotmWkvCVg&hl=sk&ei=aTxcSvu9HoyF_AbQl6HwDA&sa=X&oi=book_res ult&ct=result&resnum=7 (valid: December 5, 2009).
5. http://www.gaiaresearch.co.za/hydroperoxide.html (valid: December 5, 2009).
6. Y.-Z. Fang, S. Yang, G. Wu, Nutrition, 18 (2002) 872-897.
7. M. Martínez-Cayuela, Biochimie, 77 (1995) 147-161.
8. W. Dröge, Physiol. Rev., 82 (2002) 47-95.
9. B. Halliwell, J.R. Hoult, D.R. Blake, FASEB J., 2 (1988) 2867-2873.
10. J. Schiller, B. Fuchs, J. Arnhold, K. Arnold, Curr. Med. Chem., 10 (2003) 2123-2145.
11. K.D. Brandt, "An Atlas of Osteoarthritis" The Parthenon Publishing Group Inc., 2001, NY, USA.
12. G. Kogan, L. Šoltés, Hyaluronan-A High-Molar-Mass Messenger Reporting on the Status of Synovial Joints: Part I. Physiological Status, within this book
13. http://en.wikipedia.org/wiki/inflammation (valid: December 5, 2009).
14. N. Shukla, J. Maher, J. Masters, G.D. Angelini, J.Y. Jeremy, Atherosclerosis, 187 (2006) 238-250.
15. L. Šoltés, G. Kogan, "Impact of transition metals in the free-radical degradation of hyaluronan biopolymer" in the book "Kinetics & Thermodynamics for Chemistry & Biochemistry, Vol. 2", pp. 181-199, Eds. E.M. Pearce, G.E. Zaikov, G. Kirshenbaum, Nova Science Publishers, New York 2009;.
16. S.F. Wong, B. Halliwell, R. Richmond, W.R. Skowroneck, J. Inorg. Biochem., 14 (1981) 127-134.
17. A. Weissberger, J.E. LuValle, D.S. Jr. Thomas, J. Am. Chem. Soc., 65 (1943) 1934-1939.
18. M.M. Khan, A.E. Martell, J. Am. Chem. Soc., 89 (1967) 4176-4185.
19. A.E.O. Fisher, D.P. Naughton, Med. Hypotheses, 61 (2003) 657-660.
20. A.E.O. Fisher, D.P. Naughton, Nutr. J., 3 (2004) 1-5.
21. A.E.O. Fisher, D.P. Naughton, Curr. Drug Deliv., 2 (2005) 261-268.
22. L. Šoltés, M. Stankovská, V. Brezová, J. Schiller, J. Arnhold, G. Kogan, P. Gemeiner, Carbohydr. Res., 341 (2006) 2826-2834.
23. K. Valachová, G. Kogan, P. Gemeiner, L. Šoltés, "Hyaluronan degradation by ascorbate: Protective effects of manganese(II) chloride" in the book "Kinetics & Thermodynamics for Chemistry & Biochemistry, Vol. 2", pp. 201-215, Eds. E.M. Pearce, G.E. Zaikov, G. Kirshenbaum, Nova Science Publishers, New York 2009;.
24. D. Jiang, J. Liang, P.W. Noble, Annu. Rev. Cell Dev. Biol., 23 (2007) 435-461.
25. M. Stankovská, J. Arnhold, J. Rychlý, H. Spalteholz, P. Gemeiner, L. Šoltés, Polym. Degrad. Stabil., 92 (2007) 644-652.